{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:44:58Z","timestamp":1790444698616,"version":"4.1.0"},"reference-count":164,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1053\/j.semnuclmed.2021.04.001","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T06:37:47Z","timestamp":1620283067000},"page":"485-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Variants and Pitfalls in PET\/CT Imaging of Gastrointestinal Cancers"],"prefix":"10.1053","volume":"51","author":[{"given":"Vetri Sudar","family":"Jayaprakasam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Paroder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Sch\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0001","author":"Howlader","year":"2020","journal-title":"SEER Cancer Statistics Review, 1975-2017"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0002","first-page":"1369","article-title":"A combined PET\/CT scanner for clinical oncology","volume":"41","author":"Beyer","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0003","first-page":"1807","article-title":"Expression of the prostate-specific membrane antigen","volume":"54","author":"Israeli","year":"1994","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0004","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","article-title":"Expression of prostate-specific membrane antigen in normal and malignant human tissues","volume":"30","author":"Kinoshita","year":"2006","journal-title":"World J Surg"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0005","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00259-014-2915-3","article-title":"[(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice","volume":"42","author":"Krohn","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0006","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2967\/jnumed.117.204677","article-title":"(68)Ga-PSMA-HBED-CC uptake in cervical, celiac, and sacral ganglia as an important pitfall in prostate cancer PET imaging","volume":"59","author":"Rischpler","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0007","unstructured":"Minamimoto R, Hancock S, Schneider B et al. Pilot Comparison of \u2076\u2078Ga-RM2 PET and \u2076\u2078Ga-PSMA-11 PET in Patients With Biochemically Recurrent Prostate Cancer."},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1073\/pnas.89.1.251","article-title":"Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney","volume":"89","author":"Yamada","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0009","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/RLU.0000000000001100","article-title":"Spectrum of 68Ga-DOTA TATE uptake in patients with neuroendocrine tumors","volume":"41","author":"Moradi","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0010","unstructured":"Gugger M, Waser B Fau - Kappeler A, Kappeler A Fau - Schonbrunn A et al. Cellular Detection of sst2A Receptors in Human Gastrointestinal Tissue."},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0011","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11307-011-0486-2","article-title":"Prospective evaluation of 99mTc MDP scintigraphy, 18F NaF PET\/CT, and 18F FDG PET\/CT for detection of skeletal metastases","volume":"14","author":"Iagaru","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0012","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1148\/rg.345130061","article-title":"Newer PET application with an old tracer: role of 18F-NaF skeletal PET\/CT in oncologic practice","volume":"34","author":"Bastawrous","year":"2014","journal-title":"Radiographics"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0013","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/j.semnuclmed.2004.06.004","article-title":"Positron emission tomography for prostate, bladder, and renal cancer","volume":"34","author":"Sch\u00f6der","year":"2004","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0014","doi-asserted-by":"crossref","first-page":"e12311","DOI":"10.1097\/MD.0000000000012311","article-title":"11C-acetate and 18F-fluorodeoxyglucose positron emission tomography\/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization","volume":"97","author":"Park","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cpet.2014.03.006","article-title":"\u00b9\u00b9C-acetate PET\/CT imaging: physiologic uptake, variants, and pitfalls","volume":"9","author":"Karanikas","year":"2014","journal-title":"PET Clin"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0016","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11307-011-0488-0","article-title":"Initial results with (11)C-acetate positron emission tomography\/computed tomography (PET\/CT) in the staging of urinary bladder cancer","volume":"14","author":"Sch\u00f6der","year":"2012","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0017","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.2967\/jnumed.108.055087","article-title":"A prospective evaluation of 18F-FDG and 11C-acetate PET\/CT for detection of primary and metastatic hepatocellular carcinoma","volume":"49","author":"Park","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0018","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nucmedbio.2017.04.004","article-title":"PET\/CT with 18F\u2013choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients","volume":"51","author":"Calabria","year":"2017","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0019","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2967\/jnumed.119.233098","article-title":"(11)C-Choline PET\/CT in recurrent prostate cancer: retrospective analysis in a large U.S. patient series","volume":"61","author":"Michaud","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1381612820666140915120742","article-title":"Clinical applications of choline PET\/CT in brain tumors","volume":"21","author":"Giovannini","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0021","first-page":"83","article-title":"Applications of PET imaging with radiolabelled choline (11C\/18F-choline)","volume":"59","author":"Kirienko","year":"2015","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0022","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.2174\/1381612821666150818110422","article-title":"Bio-Distribution, Imaging Protocols and Diagnostic Accuracy of PET with Tracers of Lipogenesis in Imaging Prostate Cancer: a Comparison between 11C-Choline, 18FFluoroethylcholine and 18F-Methylcholine","volume":"21","author":"Calabria","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0023","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/MNM.0000000000000372","article-title":"Multicenter study evaluating extraprostatic uptake of 11C-choline, 18F-methylcholine, and 18F-ethylcholine in male patients: physiological distribution, statistical differences, imaging pearls, and normal variants","volume":"36","author":"Haroon","year":"2015","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0024","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1111\/ans.13739","article-title":"Detection of incidental colorectal pathology on positron emission tomography\/computed tomography","volume":"88","author":"Mui","year":"2018","journal-title":"ANZ J Surg"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0025","first-page":"3090","article-title":"Methionine dependency of cell growth in normal and malignant hematopoietic cells","volume":"42","author":"Kano","year":"1982","journal-title":"Cancer Res"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0026","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11060-010-0117-9","article-title":"Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas","volume":"99","author":"Okubo","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0027","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3348\/kjr.2016.17.3.424","article-title":"Imaging spectrum and pitfalls of (11)C-methionine positron emission tomography in a series of patients with intracranial lesions","volume":"17","author":"Ito","year":"2016","journal-title":"Korean J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0028","first-page":"2196","article-title":"Metabolic imaging of ovarian tumors with carbon-11-methionine: a PET study","volume":"36","author":"Lapela","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2191-219X-3-27","article-title":"Optimization of [11C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV","volume":"3","author":"Isohashi","year":"2013","journal-title":"EJNMMI Res"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0030","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00006676-199905000-00010","article-title":"11C-methionine uptake to the pancreas and its secretion: a positron emission tomography study in humans","volume":"18","author":"Takasu","year":"1999","journal-title":"Pancreas"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0031","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2967\/jnumed.115.170456","article-title":"Initial results of a prospective clinical trial of 18F-fluciclovine PET\/CT in newly diagnosed invasive ductal and invasive lobular breast cancers","volume":"57","author":"Ulaner","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0032","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00259-019-04433-1","article-title":"18 F-Fluciclovine (18 F-FACBC) PET imaging of recurrent brain tumors","volume":"47","author":"Michaud","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0033","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2967\/jnumed.114.143628","article-title":"Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease","volume":"55","author":"Schuster","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0034","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cpet.2014.03.007","article-title":"\u00b9\u2078F-DOPA PET\/computed tomography imaging","volume":"9","author":"Chondrogiannis","year":"2014","journal-title":"PET Clin"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","article-title":"Guideline for PET\/CT imaging of neuroendocrine neoplasms with (68)Ga-DOTA-conjugated somatostatin receptor targeting peptides and (18)F-DOPA","volume":"44","author":"Bozkurt","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0036","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00259-018-4240-8","article-title":"18)F-DOPA PET\/CT in brain tumors: impact on multidisciplinary brain tumor board decisions","volume":"46","author":"Humbert","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0037","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/j.semnuclmed.2007.08.001","article-title":"FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3\u2032-deoxy-3\u2032-[18F]fluorothymidine","volume":"37","author":"Salskov","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0038","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2967\/jnumed.107.044867","article-title":"Imaging gastric cancer with PET and the radiotracers 18F-FLT and 18F-FDG: a comparative analysis","volume":"48","author":"Herrmann","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0039","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/RLU.0000000000001820","article-title":"89Zr-trastuzumab PET\/CT for detection of human epidermal growth factor receptor 2-positive metastases in patients with human epidermal growth factor receptor 2-negative primary breast cancer","volume":"42","author":"Ulaner","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1158\/2159-8290.CD-18-0598","article-title":"EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer","volume":"9","author":"Sanchez-Vega","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0041","doi-asserted-by":"crossref","first-page":"900","DOI":"10.2967\/jnumed.117.202010","article-title":"First-in-human human epidermal growth factor receptor 2-targeted imaging using (89)Zr-Pertuzumab PET\/CT: dosimetry and clinical application in patients with breast cancer","volume":"59","author":"Ulaner","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0042","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2967\/jnumed.117.194555","article-title":"Pharmacokinetics, biodistribution, and radiation dosimetry for pharmacokinetics, biodistribution, and radiation dosimetry for 89 Zr-trastuzumab in patients with esophagogastric cancer","volume":"59","author":"O'Donoghue","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0043","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00259-002-0775-8","article-title":"Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET","volume":"29","author":"Eschmann","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0044","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4274\/2017.26.suppl.07","article-title":"I-124 imaging and dosimetry","volume":"26","author":"Kuker","year":"2017","journal-title":"Mol Imaging Radionucl Ther"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0045","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2967\/jnumed.118.219576","article-title":"Biodistribution and dosimetry of intraventricularly administered (124)I-Omburtamab in patients with metastatic leptomeningeal tumors","volume":"60","author":"Pandit-Taskar","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0046","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.3390\/molecules15042686","article-title":"Iodine-124: a promising positron emitter for organic PET chemistry","volume":"15","author":"Koehler","year":"2010","journal-title":"Molecules"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0047","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1007\/s00259-008-0756-7","article-title":"Correction of oral contrast artifacts in CT-based attenuation correction of PET images using an automated segmentation algorithm","volume":"35","author":"Ahmadian","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0048","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.semnuclmed.2003.12.003","article-title":"Pitfalls and artifacts in 18FDG PET and PET\/CT oncologic imaging","volume":"34","author":"Cook","year":"2004","journal-title":"Semin Nucl Med"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2021.04.001_bib0049","first-page":"25S","article-title":"Acquisition protocol considerations for combined PET\/CT imaging","volume":"45","author":"Beyer","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0050","doi-asserted-by":"crossref","first-page":"S2671","DOI":"10.21037\/jtd.2018.03.182","article-title":"Clinical implication of the innovations of the 8 th edition of the TNM classification for esophageal and esophago-gastric cancer","volume":"10","author":"XB","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0051","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11748-009-0457-6","article-title":"Abnormal fluorine-18-fluorodeoxyglucose uptake in benign esophageal leiomyoma","volume":"57","author":"Miyoshi","year":"2009","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0052","first-page":"1804","article-title":"Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET\/CT: correlation with endoscopic and histopathologic results","volume":"45","author":"Kamel","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0053","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/RLU.0000000000002881","article-title":"Advanced case of achalasia that appeared on 68Ga-prostate-specific membrane antigen PET\/CT","volume":"45","author":"Shakeri","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0054","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11307-005-0017-0","article-title":"Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer","volume":"7","author":"Lowe","year":"2005","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0055","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1097\/JTO.0000000000000222","article-title":"Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET\/CT have a role?","volume":"9","author":"Cuellar","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0056","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.suronc.2013.02.003","article-title":"Meta-analysis of 18FDG PET-CT for nodal staging in patients with esophageal cancer","volume":"22","author":"Shi","year":"2013","journal-title":"Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0057","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1200\/JCO.2001.19.12.3058","article-title":"Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging","volume":"19","author":"Weber","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0058","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/bjc.2015.416","article-title":"Prognostic significance of PET assessment of metabolic response to therapy in oesophageal squamous cell carcinoma","volume":"113","author":"Chhabra","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0059","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jtho.2019.04.004","article-title":"Detecting pathological complete response in esophageal cancer after neoadjuvant therapy based on imaging techniques: A diagnostic systematic review and meta-analysis","volume":"14","author":"de Gouw","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0060","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2967\/jnumed.115.155580","article-title":"Diagnostic performance of \u00b9\u2078F-FDG PET and PET\/CT for the detection of recurrent esophageal cancer after treatment with curative intent: A systematic review and meta-analysis","volume":"56","author":"Goense","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0061","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s00259-019-04387-4","article-title":"Diagnostic value of surveillance (18)F-fluorodeoxyglucose PET\/CT for detecting recurrent esophageal carcinoma after curative treatment","volume":"46","author":"Kim","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0062","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.gtc.2013.01.004","article-title":"Pathology of gastric cancer and its precursor lesions","volume":"42","author":"Yakirevich","year":"2013","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0063","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.17219\/acem\/94068","article-title":"Gastrointestinal non-Hodgkin lymphomas","volume":"28","author":"Olszewska-Szopa","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0064","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF02984984","article-title":"An analysis of the physiological FDG uptake pattern in the stomach","volume":"17","author":"Koga","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0065","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00259-015-3211-6","article-title":"Incremental diagnostic utility of gastric distension FDG PET\/CT","volume":"43","author":"Le Roux","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0066","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s12149-012-0621-4","article-title":"Xanthogranulomatous gastritis mimicking malignant GIST on F-18 FDG PET","volume":"26","author":"Tsukada","year":"2012","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0067","first-page":"74","article-title":"Gastric Schwannoma mimicking malignant gastrointestinal stromal tumor and misdiagnosed by (18)F-FDG PET\/CT","volume":"18","author":"Zhang","year":"2015","journal-title":"Hell J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0068","first-page":"257","article-title":"\u00b9\u2078F-FDG PET\/CT and contrast enhanced CT in differential diagnosis between leiomyoma and gastrointestinal stromal tumor","volume":"18","author":"Hirose","year":"2015","journal-title":"Hell J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0069","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/RLU.0000000000001491","article-title":"Gastrointestinal stromal tumor showing intense tracer uptake on PSMA PET\/CT","volume":"42","author":"Noto","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/RLU.0000000000001902","article-title":"68Ga-prostate-specific membrane antigen uptake in gastrointestinal stromal tumor","volume":"43","author":"Laurens","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0071","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1097\/RLU.0000000000003289","article-title":"An Incidental Uptake of 18F-Choline at PET\/CT in Gastric Neuroendocrine Tumor","volume":"46","author":"Evangelista","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0072","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1002\/cncr.27550","article-title":"A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer","volume":"118","author":"Smyth","year":"2012","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0073","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejso.2016.08.020","article-title":"(18)FDG-PET-CT improves specificity of preoperative lymph-node staging in patients with intestinal but not diffuse-type esophagogastric adenocarcinoma","volume":"43","author":"Lehmann","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0074","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00259-018-3993-4","article-title":"Ga-labelled PSMA (prostate specific membrane antigen) expression in signet-ring cell gastric carcinoma","volume":"45","author":"Malik","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hon.2152","article-title":"Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis","volume":"33","author":"Treglia","year":"2015","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0076","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2017013698","article-title":"Uptake of [(18)F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma","volume":"2","author":"Qi","year":"2018","journal-title":"Blood Adv"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0077","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00259-008-0771-8","article-title":"FDG avidity and PET\/CT patterns in primary gastric lymphoma","volume":"35","author":"Radan","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0078","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.clml.2019.10.006","article-title":"18F-FDG PET\/CT or PET role in MALT lymphoma: An open issue not yet solved\u2014a critical review","volume":"20","author":"Albano","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0079","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1158\/1078-0432.CCR-07-0934","article-title":"Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study","volume":"14","author":"Ott","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0080","doi-asserted-by":"crossref","first-page":"506","DOI":"10.21037\/jgo.2016.06.01","article-title":"Use of positron emission tomography scan response to guide treatment change for locally advanced gastric cancer: the Memorial Sloan Kettering Cancer Center experience","volume":"7","author":"Won","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0081","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00259-015-3249-5","article-title":"Diagnostic performance of FDG PET\/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection","volume":"43","author":"Lee","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0082","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3892\/etm.2020.9595","article-title":"Accuracy of (18)F-FDG PET\/CT and CECT for primary staging and diagnosis of recurrent gastric cancer: A meta-analysis","volume":"21","author":"Zhang","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0083","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.6004\/jnccn.2019.0043","article-title":"Small bowel adenocarcinoma, Version 1.2020, NCCN clinical practice guidelines in oncology","volume":"17","author":"Benson","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0084","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0085","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/MNM.0000000000000566","article-title":"Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET\/CT imaging","volume":"37","author":"Demirci","year":"2016","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0086","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/pros.21090","article-title":"Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer","volume":"70","author":"Wolf","year":"2010","journal-title":"Prostate"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0087","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1259\/bjr\/64534573","article-title":"Utility of positron emission tomography\/CT in the evaluation of small bowel pathology","volume":"85","author":"Cronin","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0088","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2967\/jnumed.107.040436","article-title":"Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET\/CT","volume":"48","author":"Louis","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0089","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00268-014-2759-9","article-title":"Adult intussusception: a retrospective review","volume":"39","author":"Honjo","year":"2015","journal-title":"World J Surg"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0090","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.3748\/wjg.v11.i46.7284","article-title":"Lymphomatous involvement of gastrointestinal tract: Evaluation by positron emission tomography with (18)F-fluorodeoxyglucose","volume":"11","author":"Phongkitkarun","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0091","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2967\/jnumed.109.069765","article-title":"Functional imaging of neuroendocrine tumors: A head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET","volume":"51","author":"Binderup","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0092","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1007\/s00259-010-1512-3","article-title":"Procedure guidelines for PET\/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE","volume":"37","author":"Virgolini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0093","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2967\/jnumed.115.166017","article-title":"The Impact of 68Ga-DOTATATE PET\/CT imaging on management of patients with neuroendocrine tumors: Experience from a national referral center in the United Kingdom","volume":"57","author":"Skoura","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0094","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2967\/jnumed.116.186361","article-title":"Current concepts in 68Ga-DOTATATE imaging of neuroendocrine neoplasms: Interpretation, biodistribution, dosimetry, and molecular strategies","volume":"58","author":"Bodei","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0095","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/RLU.0000000000002467","article-title":"Hepatocellular carcinoma mimicking neuroendocrine tumor metastasis on 68Ga-DOTATATE PET\/CT","volume":"44","author":"Ulaner","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0096","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/RLU.0000000000003400","article-title":"Duodenal adenocarcinoma mimicking metastasis of prostate cancer on 18F-prostate-specific membrane antigen-1007 PET\/CT","volume":"46","author":"Soeda","year":"2021","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0097","article-title":"Incidental finding of ileal gastrointestinal stromal tumour during prostate cancer staging with prostate-specific membrane antigen scan","author":"Lee","year":"2020","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0098","first-page":"1467","volume":"394","author":"Dekker","year":"2019","journal-title":"Colorectal cancer. Lancet"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0099","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2007.12.002","article-title":"Pathophysiology, clinical presentation, and management of colon cancer","volume":"37","author":"Cappell","year":"2008","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.6004\/jnccn.2017.0038","article-title":"Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes","volume":"15","author":"Lee","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0101","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1148\/radiol.2243011214","article-title":"Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings","volume":"224","author":"Tatlidil","year":"2002","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00003072-199801000-00002","article-title":"Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer","volume":"23","author":"Miraldi","year":"1998","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0103","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003495-200565030-00005","article-title":"Oral antidiabetic agents: current role in type 2 diabetes mellitus","volume":"65","author":"Krentz","year":"2005","journal-title":"Drugs"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0104","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1042\/BJ20040694","article-title":"5-aminoimidazole-4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK","volume":"385","author":"Walker","year":"2005","journal-title":"Biochem J"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","article-title":"High and typical 18F-FDG bowel uptake in patients treated with metformin","volume":"35","author":"Gontier","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0106","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12149-020-01509-z","article-title":"Discontinuation of metformin to prevent metformin-induced high colonic FDG uptake: is 48 h sufficient?","volume":"34","author":"Schreuder","year":"2020","journal-title":"Annals of nuclear medicine"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0107","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2967\/jnumed.109.073130","article-title":"PET\/CT enterography in Crohn disease: correlation of disease activity on CT enterography with 18F-FDG uptake","volume":"51","author":"Groshar","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0108","first-page":"1683","article-title":"Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous colitis","volume":"37","author":"Hannah","year":"1996","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0109","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2214\/ajr.183.4.1831143","article-title":"Clinical significance of unexplained abnormal focal FDG uptake in the abdomen during whole-body PET","volume":"183","author":"Pandit-Taskar","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10151-017-1652-6","article-title":"Incidental colorectal FDG uptake on PET\/CT scan and lesions observed during subsequent colonoscopy: a systematic review","volume":"21","author":"Kousgaard","year":"2017","journal-title":"Tech Coloproctol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0111","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1007\/s00405-014-3308-8","article-title":"Prevalence and risk of malignancy of focal incidental uptake detected by fluorine-18-fluorodeoxyglucose positron emission tomography in the parotid gland: a meta-analysis","volume":"272","author":"Treglia","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0112","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12149-014-0922-x","article-title":"The potential usefulness of (18)F-FDG PET\/CT for detecting colorectal carcinoma and adenoma in asymptomatic adults","volume":"29","author":"Hwang","year":"2015","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0113","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.crad.2014.01.009","article-title":"Diagnostic accuracy of \u00b9\u2078F-FDG PET\/CT for detection of advanced colorectal adenoma","volume":"69","author":"Gollub","year":"2014","journal-title":"Clin Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0114","doi-asserted-by":"crossref","first-page":"421","DOI":"10.5694\/mja2.50276","article-title":"The management of diverticulitis: a review of the guidelines","volume":"211","author":"You","year":"2019","journal-title":"Med J Aust"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3892\/ol.2013.1702","article-title":"Correlation between incidental FDG PET\/CT colorectal observations and endoscopic and histopathological results","volume":"7","author":"Rainis","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0116","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.3748\/wjg.v18.i27.3623","article-title":"Difficulty in differentiating two cases of sigmoid stenosis by diverticulitis from cancer","volume":"18","author":"Nishiyama","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0117","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/RLU.0000000000002981","article-title":"Inflammatory pseudotumor of intestine mimicking lymphoma on 18F-FDG PET\/CT","volume":"45","author":"Xue","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0118","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/RLU.0000000000002996","article-title":"Colon sarcoidosis mimicking cancer at 18F-FDG PET\/CT","volume":"45","author":"Mei","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12149-019-01330-3","article-title":"18F-FDG uptake in the normal appendix in adults: PET\/CT evaluation","volume":"33","author":"Silman","year":"2019","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0120","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1097\/RLU.0000000000003210","article-title":"18F-fluciclovine uptake in acute appendicitis","volume":"45","author":"Ahn","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0121","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s12094-015-1434-4","article-title":"SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015","volume":"17","author":"Aranda","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0122","first-page":"57","article-title":"FDG PET\/CT in colorectal cancer","volume":"39","author":"Rodr\u00edguez-Fraile","year":"2020","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0123","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2214\/ajr.174.4.1741005","article-title":"FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features","volume":"174","author":"Berger","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0124","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/MNM.0b013e328357b2d9","article-title":"A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET\/CT","volume":"33","author":"Lu","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0125","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0126","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1245\/s10434-012-2300-z","article-title":"Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: A meta-analysis","volume":"19","author":"van Kessel","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0127","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2214\/AJR.14.13210","article-title":"Value of (18)F-FDG PET for predicting response to neoadjuvant therapy in rectal cancer: systematic review and meta-analysis","volume":"204","author":"Maffione","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0128","first-page":"327","article-title":"Differentiation between peri-anastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data","volume":"54","author":"Smeets","year":"2010","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0129","first-page":"343","article-title":"Early postoperative FDG-PET-CT imaging results in a relevant upstaging in the pN2 subgroup of stage III colorectal cancer patients","volume":"16","author":"Fehr","year":"2017","journal-title":"Clin Colorectal Cancer"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0130","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1097\/RLU.0000000000000692","article-title":"Early postoperative 18F-FDG PET\/CT in high-risk stage III colorectal cancer","volume":"40","author":"Wasserberg","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0131","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2020.10.012","article-title":"Comparison of 18FDG-PET\/CT and conventional follow-up methods in colorectal cancer: A randomised prospective study","volume":"53","author":"Monteil","year":"2021","journal-title":"Digestive and Liver Disease"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0132","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00384-013-1659-z","article-title":"Use of FDG-PET or PET\/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis","volume":"28","author":"Lu","year":"2013","journal-title":"Int J Colorectal Dis"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0133","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s12149-012-0609-0","article-title":"The utility of FDG-PET\/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels","volume":"26","author":"Sanli","year":"2012","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0134","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3393\/ac.2017.09.21","article-title":"Clinical etiology of hypermetabolic pelvic lesions in postoperative positron emission tomography\/computed tomography for patients with rectal and sigmoid cancer","volume":"34","author":"Kang","year":"2018","journal-title":"Ann Coloproctol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0135","first-page":"924","article-title":"International trends in anal cancer incidence rates","volume":"46","author":"Islami","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0136","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1158\/1055-9965.EPI-19-0601","article-title":"Risk of anal cancer following benign anal disease and anal cancer precursor lesions: A Danish Nationwide Cohort Study","volume":"29","author":"Faber","year":"2020","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0137","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12149-020-01480-9","article-title":"Physiological 18F-FDG uptake in the normal adult anal canal: evaluation by PET\/CT","volume":"34","author":"Sena","year":"2020","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0138","first-page":"257","article-title":"Avid 18F-FDG uptake in rectal hemorrhoid in a patient with metastatic medullary carcinoma of thyroid","volume":"25","author":"Basu","year":"2006","journal-title":"Indian J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0139","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00261-010-9670-0","article-title":"Findings of 2-fluoro-2-deoxy-d-glucose positron emission tomography in hemorrhoids","volume":"36","author":"Tsai","year":"2011","journal-title":"Abdom Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0140","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2214\/AJR.13.12256","article-title":"FDG PET\/CT in the management of colorectal and anal cancers","volume":"203","author":"Agarwal","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0141","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.critrevonc.2018.03.013","article-title":"Positron emission tomography and computed tomographic (PET\/CT) imaging for radiation therapy planning in anal cancer: A systematic review and meta-analysis","volume":"126","author":"Albertsson","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0142","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2967\/jnumed.116.185280","article-title":"Role of (18)F-FDG PET\/CT in posttreatment evaluation of anal carcinoma","volume":"58","author":"Houard","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0143","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170370","article-title":"PET imaging in anal canal cancer: a systematic review and meta-analysis","volume":"90","author":"Mahmud","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0144","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijrobp.2007.09.005","article-title":"Tumor response and survival predicted by post-therapy FDG-PET\/CT in anal cancer","volume":"71","author":"Schwarz","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0145","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1097\/RLU.0000000000002934","article-title":"Presacral anastomotic sinus after low anterior resection mimicking recurrent rectal cancer","volume":"45","author":"Kim","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0146","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clinimag.2016.08.019","article-title":"Characteristics of 18F-fluorodeoxyglucose uptake in anastomotic sinus and fistula following rectal cancer surgery","volume":"41","author":"Kang","year":"2017","journal-title":"Clin Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0147","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/RLU.0b013e3181d18ccb","article-title":"Demonstration of a tubercular fistula-in-ano on F-18 FDG PET\/CT","volume":"35","author":"Garg","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0148","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/MNM.0000000000000560","article-title":"Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer","volume":"37","author":"Teagle","year":"2016","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0149","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2214\/AJR.07.2083","article-title":"Benign nonphysiologic lesions with increased 18F-FDG uptake on PET\/CT: Characterization and incidence","volume":"189","author":"Metser","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10029-017-1596-9","article-title":"Postoperative changes after surgical mesh hernia repair: A pitfall in interpretation of 18F-FDG PET-CT","volume":"21","author":"Davidson","year":"2017","journal-title":"Hernia"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0151","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1445-2197.2008.04487.x","article-title":"Splenosis presenting as multiple intra-abdominal masses mimicking malignancy","volume":"78","author":"Kok","year":"2008","journal-title":"ANZ J Surg"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0152","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MNM.0000000000000785","article-title":"Physiologic uptake of 18F-FDG in transposed ovaries may mimic metastasis on 18F-FDG PET\/CT imaging","volume":"39","author":"Davidson","year":"2018","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0153","doi-asserted-by":"crossref","DOI":"10.1186\/2193-1801-2-113","article-title":"FDG-PET\/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment","volume":"2","author":"Inoue","year":"2013","journal-title":"Springerplus"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0154","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/tid.12619","article-title":"Gastrointestinal histoplasmosis in a patient after autologous stem cell transplant for multiple myeloma","volume":"18","author":"Mohan","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0155","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/RLU.0000000000001307","article-title":"Imaging of hepatic ectopic pregnancy by 18F-FDG PET\/CT","volume":"41","author":"Hao","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0156","first-page":"2011","article-title":"Acute portal vein thrombosis: An important mimic of malignancy on FDG PET\/CT","author":"Cowell","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0157","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00259-004-1577-y","article-title":"Value of 18F-FDG PET in the detection of peritoneal carcinomatosis","volume":"31","author":"Suzuki","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0158","article-title":"Diagnostic accuracy of (18)F-FDG PET\/CT for detection of peritoneal carcinomatosis; a systematic review and meta-analysis","volume":"91","author":"Kim","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0159","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jviscsurg.2015.06.003","article-title":"Pitfalls and mimickers on (18)F-FDG-PET\/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients","volume":"152","author":"Audollent","year":"2015","journal-title":"J Visc Surg"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0160","doi-asserted-by":"crossref","first-page":"W523","DOI":"10.2214\/AJR.09.2936","article-title":"Spectrum of (18)F-FDG PET\/CT appearances in peritoneal disease","volume":"193","author":"Anthony","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0161","first-page":"203","article-title":"Clinical value of positron emission tomography-computed tomography combined with ultrasound in detection of primary tumors in patients with malignant ascites","volume":"34","author":"Liu","year":"2019","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0162","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2967\/jnumed.108.056382","article-title":"The role of 18F-FDG PET\/CT in the evaluation of ascites of undetermined origin","volume":"50","author":"Zhang","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0163","doi-asserted-by":"crossref","first-page":"766","DOI":"10.14309\/ajg.0000000000000620","article-title":"Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study","volume":"115","author":"Pan","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2021.04.001_bib0164","first-page":"1","article-title":"Abdominal imaging findings in patients with SARS-CoV-2 infection: A scoping review","author":"Lui","year":"2020","journal-title":"Abdom Radiol (NY)"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299821000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299821000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:37:55Z","timestamp":1757543875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299821000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":164,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0001299821000179"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.04.001","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variants and Pitfalls in PET\/CT Imaging of Gastrointestinal Cancers","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}